“Study the technical validity and feasibility of serum HER-2/Neu and its correlation with tissue HER-2 status in female breast cancer patients only”, Asian J Med Sci, vol. 14, no. 11, pp. 228–233, Nov. 2023, doi: 10.3126/ajms.v14i11.55260.